The organization of human leucocyte antigen class I epitopes in HIV genome products: implications for HIV evolution and vaccine design

Author： Chao Z.   Cornette J.L.   Berzofsky J.A.   DeLisi C.  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.15, Iss.12, 1997-08, pp. : 1291-1302

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HIV and chemokines: Implications for therapy and vaccine

By Lusso P.  

Vaccine, Vol. 20, Iss. 15, 2002-05 ,pp. : 1964-1967

Elsevier

Access to resources Recommend Favorite

Correlates of protection, antigen delivery and molecular epidemiology: basics for designing an HIV vaccine

By Wagner R.   Shao Y.   Wolf H.  

Vaccine, Vol. 17, Iss. 13, 1999-01 ,pp. : 1706-1710

Elsevier

Access to resources Recommend Favorite

Association of human leucocyte antigen phenotype with vaccine efficacy in patients receiving vaginal mucosal immunization for recurrent urinary tract infection

By Hopkins W.J.   Heisey D.M.   Uehling D.T.  

Vaccine, Vol. 17, Iss. 2, 1999-01 ,pp. : 169-171

Elsevier

Access to resources Recommend Favorite

Infection of mouse bone marrow-derived dendritic cells with recombinant adenovirus vectors leads to presentation of encoded antigen by both MHC class I and class II molecules-potential benefits in vaccine design

By Herrera O.B.   Brett S.   Lechler R.I.  

Vaccine, Vol. 21, Iss. 3, 2002-12 ,pp. : 231-242

Elsevier

Access to resources Recommend Favorite

Challenges in the Search for an HIV Vaccine

By Lemckert Angelique A.C.   Goudsmit Jaap   Barouch Dan h.  

European Journal of Epidemiology, Vol. 19, Iss. 6, 2004-06 ,pp. : 513-516

Springer Publishing Company

Access to resources Recommend Favorite